Gilead says remdesivir cuts death risk

Name: Gilead says remdesivir cuts death risk
Uploaded: 2020-07-10T16:31:14+00:00
Duration: P64S
Description: Gilead Sciences said Friday additional data from a late-stage study showed its antiviral remdesivir reduced the risk of death and significantly improved the

Video Credit: Reuters Studio - Duration: 01:04s - Published on July 10, 2020

Gilead says remdesivir cuts death risk

Gilead Sciences said Friday additional data from a late-stage study showed its antiviral remdesivir reduced the risk of death and significantly improved the conditions of severely ill COVID-19 patients.

Fred Katayama reports.

0 shares	Share Tweet Save Post Send

Related videos from verified sources

Drugmaker Says Remdesivir Can Lower COVID-19 Death Risk By 62% [Video]

Drugmaker Says Remdesivir Can Lower COVID-19 Death Risk By 62%

The antiviral drug Remdesivir has proven to be effective in the treatment of COVID-19. According to UPI, the drug can lower the risk of death in COVID-19 patients by 62%. U.S. drugmaker Gilead Sciences..

Credit: Wochit Tech Duration: 00:32Published on July 14, 2020

Gilead says remdesivir cuts death risk

You Might Like

Related videos from verified sources